Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Endoform Topical Matrix

K-Number: K171231 · 2017-06-14

ApplicantAroa Biosurgery
Decision Date2017-06-14
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

Endoform Topical Matrix is a medical device manufactured by Aroa Biosurgery. It received FDA 510(k) clearance on 2017-06-14 under approval number K171231. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Endoform Topical Matrix?

Endoform Topical Matrix is a medical device that received FDA 510(k) clearance on 2017-06-14. It is manufactured by Aroa Biosurgery. The 510(k) number is K171231.

When was Endoform Topical Matrix approved by the FDA?

Endoform Topical Matrix received FDA 510(k) clearance on 2017-06-14, under approval number K171231.

What company makes Endoform Topical Matrix?

Endoform Topical Matrix is manufactured by Aroa Biosurgery.

What is the FDA product code for Endoform Topical Matrix?

The FDA product code for Endoform Topical Matrix is KGN.

Other Devices by Aroa Biosurgery

K172318Endoform Silver Dermal Template

Related Devices (Code: KGN)

K160136Flowable Wound MatrixCook Biotech Incorporated K152600Collagen Dental Wound DressingsCollagen Matrix, Inc. K153754MicroMatrixAcell, Inc. K153690PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. K172010gel-e BandageGel-E, Inc. (Formerly Remedium Technologies, Inc.) K171842Geistlich Wound MatrixGeistlich Pharma AG

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑